Royal Bank of Canada
OCDX

Royal Bank of Canada’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Royal Bank of Canada’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,794
Closed -$463K – 8187
2022
Q1 		$463K Sell
24,794
-28,062
-53% -$505K ﹤0.01% 4340
2021
Q4 		$1.13M Buy
52,856
+31,342
+146% +$618K ﹤0.01% 3682
2021
Q3 		$398K Buy
21,514
+13,224
+160% +$266K ﹤0.01% 4538
2021
Q2 		$178K Buy
8,290
+907
+12% +$18.4K ﹤0.01% 5175
2021
Q1 		$143K Buy
+7,383
New +$130K ﹤0.01% 5188

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Royal Bank of Canada's OCDX Position: Q2 2022 in Review

Royal Bank of Canada sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 24,794 shares — an estimated $463K sold.

Royal Bank of Canada first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $1.13M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Royal Bank of Canada reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 24,794 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $463K.
  • Royal Bank of Canada first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
  • Royal Bank of Canada's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.13M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.